inTrigue - Impact on your rare disease business
Volv has spent three years developing its flagship product called inTrigue, which finds misdiagnosed and undiagnosed rare disease patients from electronic health care records (EHRs). inTrigue is based on an entirely original use of artificial intelligence and machine learning, together with a set of established in-country processes that access tens of millions of EHRs.
What inTrigue does is fundamentally change the nature of your understanding of prevalence in each country you are interested in. By deriving highly accurate models for identifying patient cohorts, we deliver empirically based prevalence numbers which are then optionally validated by expert clinicians in the medical setting.
This can have a profound impact on your business, as armed with some concrete numbers, your organisation can consolidate their activities around one set of numbers rather than several contested scientific papers. Not only that, when engaging with regulatory authorities and payers, the substantive evidence based position can stand you in good stead getting the respect and trust that helps obtaining the approvals that you need.